It is not first time in ASX where price being manipulated after a significant announcement. What I can say at this state if we've a commercial deal with with China and US the upfront revenue could be in order of $20M each with conditional revenue in the range of 250M each on the basis of ADVANZ pharma deal. If the commercial agreement happens after the March report and results have statistical significance, double the that amount.
Just sit down and get relaxed. We're surrounded by vultures who want your cheap share as cheap as possible and they will downplay everything, some all of sudden will become Medical Statistician, can interpret double blind reports, talk about futility, take a blind fold on upcoming commercial agreement, will not accept the recent recept of $11.7M revenue (with potential revenue of $232M) from Advanz pharma.
HOLD it tight and keep believing in DXB team, we'll be part of their success journey.
- Forums
- ASX - By Stock
- Ann: ACTION3 IND Approved in China
It is not first time in ASX where price being manipulated after...
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
41.0¢ |
Change
-0.025(5.75%) |
Mkt cap ! $225.7M |
Open | High | Low | Value | Volume |
43.0¢ | 43.5¢ | 40.5¢ | $1.405M | 3.385M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 78254 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 83356 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 78254 | 0.410 |
7 | 245851 | 0.405 |
9 | 359920 | 0.400 |
3 | 32069 | 0.395 |
5 | 65982 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 83356 | 2 |
0.425 | 42170 | 2 |
0.430 | 60542 | 4 |
0.435 | 160170 | 4 |
0.440 | 170000 | 3 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |